| 2026-03-10 |
详情>>
内部人交易：
Castagna Michael股份增加100000.00股
|
| 2026-02-26 |
详情>>
股本变动：
变动后总股本30810.04万股
|
| 2026-02-26 |
详情>>
业绩披露：
2025年年报每股收益0.02美元,归母净利润586.30万美元,同比去年增长-78.75%
|
| 2026-02-26 |
财报披露：
美东时间 2026-02-26 盘前发布财报
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.07美元,归母净利润2181.10万美元,同比去年增长8.16%
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益0.05美元,归母净利润1382.60万美元,同比去年增长60.47%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益0.04美元,归母净利润1315.80万美元,同比去年增长23.78%
|
| 2025-04-01 |
股东大会：
将于2025-05-14召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected
2.To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting;
3.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2025;
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2025-02-26 |
详情>>
业绩披露：
2022年年报每股收益-0.34美元,归母净利润-8740万美元,同比去年增长-8%
|
| 2025-02-26 |
详情>>
业绩披露：
2024年年报每股收益0.10美元,归母净利润2758.80万美元,同比去年增长331.09%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.07美元,归母净利润2016.60万美元,同比去年增长251.18%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益0.03美元,归母净利润861.60万美元,同比去年增长157.21%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益0.04美元,归母净利润1063.00万美元,同比去年增长208.52%
|
| 2024-04-05 |
股东大会：
将于2024-05-15召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected;
2.To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting;
3.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2024;
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2024-02-27 |
详情>>
业绩披露：
2023年年报每股收益-0.04美元,归母净利润-1193.8万美元,同比去年增长86.34%
|
| 2023-04-10 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected
2.To approve an amendment to MannKind’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 400,000,000 shares to 800,000,000 shares (the “Authorized Shares Increase Proposal”);
3.To authorize an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal 2;
4.To approve an amendment to the MannKind 2018 Equity Incentive Plan (as amended, the “EIP”) to increase the number of shares authorized for issuance thereunder by 25,000,000 shares;
5.To approve an amendment to the MannKind 2004 Employee Stock Purchase Plan (the “ESPP”) to increase the number of shares authorized for issuance thereunder by 3,000,000 shares;
6.To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting;
7.To indicate, on an advisory basis, the preferred frequency of stockholder advisory vote on the compensation of the named executive officers of MannKind;
8.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2023;
9.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2022-05-24 |
复牌提示：
2022-05-23 13:47:58 停牌，复牌日期 2022-05-23 13:57:58
|
| 2022-03-30 |
股东大会：
将于2022-05-10召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected
2.To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting;
3.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2022;
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-07 |
股东大会：
将于2021-05-20召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees named herein as directors to serve for the ensuing year and until their successors are elected
2.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2021
3.To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2020-04-10 |
股东大会：
将于2020-05-21召开股东大会
会议内容 ▼▲
- 1.To elect the eight nominees named herein as directors to serve for the ensuing year and until their successors are elected
2.To approve an amendment to MannKind Corporation’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 280,000,000 shares to 400,000,000 shares (the “Authorized Shares Increase Proposal”);
3.To approve an amendment to the MannKind Corporation 2018 Equity Incentive Plan to increase the number of shares authorized for issuance under the 2018 Equity Incentive Plan (the “2018 Plan”) by 12,500,000 shares;
4.To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting
5.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2020
6.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2019-03-28 |
股东大会：
将于2019-05-14召开股东大会
会议内容 ▼▲
- 1.To elect the seven nominees named herein as directors to serve for the ensuing year and until their successors are elected;
2.To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting;
3.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2019;
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2018-03-29 |
股东大会：
将于2018-05-16召开股东大会
会议内容 ▼▲
- 1.To elect the seven nominees named herein as directors to serve for the ensuing year and until their successors are elected;
2.To approve the MannKind Corporation 2018 Equity Incentive Plan;
3.To approve an amendment to the MannKind Corporation 2004 Employee Stock Purchase Plan to, among other things, increase the number of shares authorized for issuance under the 2004 Employee Stock Purchase Plan by 3,000,000 shares;
4.To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting;
5.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2018;
6.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2017-11-17 |
股东大会：
将于2017-12-13召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to MannKind Corporation’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 140,000,000 shares to 280,000,000 shares (the “Authorized Shares Increase Proposal”);
2.To authorize the adjournment of the meeting, if necessary, to solicit additional proxies if there are insufficient votes in favor of the Authorized Shares Increase Proposal;
3.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2017-04-07 |
股东大会：
将于2017-05-18召开股东大会
会议内容 ▼▲
- 1. To elect the seven nominees named herein as directors to serve for the ensuing year and until their successors are elected;
2. To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting;
3. To indicate, on an advisory basis, the preferred frequency of stockholder advisory vote on the compensation of the named executive officers of MannKind;
4. To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2017;
5. To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2017-03-02 |
详情>>
拆分方案：
每5.0000合并分成1.0000股
|
| 2017-02-13 |
股东大会：
将于2017-03-01召开股东大会
会议内容 ▼▲
- 1.To approve an amendment to our Amended and Restated Certificate of Incorporation to (i) effect a reverse stock split of our common stock at a ratio in the range of 1-for-3 to 1-for-10, with such ratio to be determined in the discretion of our board of directors and with such reverse stock split to be effected at such time and date, if at all, as determined by our board of directors in its sole discretion, and (ii) reduce the number of authorized shares of our common stock in a corresponding proportion to the reverse stock split, rounded to the nearest whole share (collectively, the “Reverse Split Proposal”);
2.To authorize an adjournment of the meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal 1;
3.To transact any other business that may be properly brought before the meeting or any continuation, adjournment or postponement thereof.
|
| 2016-04-21 |
股东大会：
将于2016-05-19召开股东大会
会议内容 ▼▲
- 1.To elect the seven nominees named herein as directors to serve for the ensuing year and until their successors are elected;
2.To approve an amendment to MannKind’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 550,000,000 to 700,000,000 shares;
3.To approve an amendment to MannKind’s 2013 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the 2013 Equity Incentive Plan by 15,000,000 shares;
4.To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind’s proxy statement for the Annual Meeting;
5.To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of MannKind for its fiscal year ending December 31, 2016;
6.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|